New Connecticut Law Allows Telemedicine Prescribing of Controlled Substances

The National Law Review, June 27, 2018

Connecticut has taken another step towards expanding the meaningful use of telemedicine in connection with treatment of mental health and substance use disorders.  SB 302, signed by Governor Dannel Malloy and effective July 1, 2018, allows providers to prescribe controlled substances via telemedicine for the treatment of psychiatric disabilities or substance use disorder, including medication assisted therapy.  The law reverses Connecticut’s prior per se ban on prescribing Schedule I, II, or II controlled substances via telehealth technologies.

Read more!